The results showed that the loss of ZBTB4 in ACC, GBMLGG, HNSC, KIPAN, KIRC, KIRP, LUAD, MESO and PAAD could predict poor disease-specific survival (Fig. 2M, N, O, P, Q, R, S, U and V). Here, ZBTB4 is linked to pancreatic adenocarcinoma.